FGFR4 p.G388R signaling (Homo sapiens)
From WikiPathways
Description
No description
Quality Tags
Ontology Terms
Bibliography
View all... |
- Kogan D, Grabner A, Yanucil C, Faul C, Ulaganathan VK; ''STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion.''; J Clin Invest, 2018 PubMed Europe PMC Scholia
- Raskov H, Orhan A, Christensen JP, Gögenur I; ''Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy.''; Br J Cancer, 2021 PubMed Europe PMC Scholia
- Ulaganathan VK, Ullrich A; ''Membrane-proximal binding of STAT3 revealed by cancer-associated receptor variants.''; Mol Cell Oncol, 2016 PubMed Europe PMC Scholia
- Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A; ''Interleukin-10 and the interleukin-10 receptor.''; Annu Rev Immunol, 2001 PubMed Europe PMC Scholia
- Ulaganathan VK, Sperl B, Rapp UR, Ullrich A; ''Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site.''; Nature, 2015 PubMed Europe PMC Scholia
- Shao H, Xu X, Mastrangelo MA, Jing N, Cook RG, Legge GB, Tweardy DJ; ''Structural requirements for signal transducer and activator of transcription 3 binding to phosphotyrosine ligands containing the YXXQ motif.''; J Biol Chem, 2004 PubMed Europe PMC Scholia
- Yu H, Kortylewski M, Pardoll D; ''Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.''; Nat Rev Immunol, 2007 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
CD334 | Protein | P22455 (Uniprot-TrEMBL) | |
Cell cycle progression | Pathway | WP179 (WikiPathways) | |
IL10 | GeneProduct | ENSG00000136634 (Ensembl) | |
IL10 | Protein | P22301 (Uniprot-TrEMBL) | |
Proliferation | Pathway | WP179 (WikiPathways) | |
STAT3 | Protein | P40763 (Uniprot-TrEMBL) |
Annotated Interactions
No annotated interactions